2 completed, 2 not yet recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Advanced Liver Fibrosis: new trials by email Literature Review of Advanced Liver Fibrosis trials Research Report on Advanced Liver Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Erlotinib for Hepatocellular Carcinoma Chemoprevention erlotinib hydrochloride, Placebo - Cirrhosis, Liver, Advanced Liver Fibrosis | Phase 2 | Not yet recruiting | University of Texas Southwestern Medical Center | 60 | 2026-12-01 | 2026-06-24 |
| Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC) Hepatocellular Carcinoma, Liver Cirrhosis | Not yet recruiting | D'Or Institute for Research and Education | 300 | 2026-09-15 | 2026-08-14 | |
| SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population FIB4 - Screening, Advanced Liver Fibrosis | Not applicable | Completed | University Hospital, Angers | 391 | 2023-10-20 | 2026-08-10 |
| A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis ALE.F02, Placebo - Advanced Liver Fibrosis, Liver Cirrhosis | Phase 1 | Completed | Alentis Therapeutics AG | 41 | 2023-04-01 | 2024-12-03 |
Liver Cirrhosis (3) · Carcinoma, Hepatocellular (2) · Hepatitis B, Chronic (1) · Liver Neoplasms (1)
Digestive System Diseases (3) · Fibrosis (3) · Liver Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Adenocarcinoma (2) · Carcinoma (2) · Digestive System Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1)
Alentis Therapeutics AG (1) · D'Or Institute for Research and Education (1) · University Hospital, Angers (1) · University of Texas Southwestern Medical Center (1)
United States (2) · France (1) · Germany (1) · Romania (1) · Slovakia (1)
Amit Singal, MD, MS (1) · Leonardo G Fonseca, MD, MSc (1) · Luigi Manenti, MD (1) · Yujin Hoshida (1)
P50CA295495 (1)